← Back to Patent Explorer
US4923855A Expired / Lapsed US ⏱️ 0.0 years remaining

Synthetic GTF chromium material and process therefor

Assignee: WILLAIM SEROY GROUP A CORP OF CA
•
Filing: 1988-04-26
•
Granted: 1990-05-08
•
Expires: 2008-04-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A novel product obtained by reacting an alkali metal salt of nicotinic acid with a trivalent chromium salt and having glucose tolerance factor activity, a process for its production and a method for its use, are disclosed.

Inventors

  • 👤 Ned L. Jensen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 16:24
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/78; C07D213/79; C07D213/80; A; A61; A61P; A61P3/00; A61P3/06; A61P3/08; A61P3/10; C07F; C07F11/00; C07F11/005

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 39 words
A method of providing chromium supplementation to mammals, comprising administering in oral dosage form an effective amount of a chromium-nicotinate GTF material obtained by contracting an alkali metal salt of nicotinic acid with a pharmaceutically acceptable trivalent chromium salt.
Claim 2
Independent Claim 39 words
A method of providing chromium supplementation to mammals, comprising administering in oral dosage form an effective amount of a chromium-nicotinate GTF material obtained by contracting an alkali metal salt of nicotinic acid with a pharmaceutically acceptable trivalent chromium salt.
Claim 3
Dependent Claim 20 words
The method of claim 1, wherein the chromium-nicotinate GTF material comprises a mixture of chromium trinicotinate and chromium dinicotinate monochloride.
Claim 4
Dependent Claim 15 words
The method of claim 1, wherein the chromium-nicotinate GTF material consists essentially of chromium trinicotinate.
Claim 5
Independent Claim 44 words
A method of providing chromium supplementation to a mammal for the purpose of improving glucose tolerance, comprising administering an effective amount of a chromium-nicotinate GTF material to the mammal, wherein the chromium-nicotinate GTF material is obtained by reacting sodium nicotinate with trivalent chromium chloride.
Claim 6
Independent Claim 44 words
A method of providing chromium supplementation to a mammal for the purpose of improving glucose tolerance, comprising administering an effective amount of a chromium-nicotinate GTF material to the mammal, wherein the chromium-nicotinate GTF material is obtained by reacting sodium nicotinate with trivalent chromium chloride.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-05-07 1993-11-06 1994-05-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-05-07 1997-11-06 1998-05-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-05-07 2001-11-06 2002-05-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag